Table 3. Labeled amounts and % enrichment in glutamate, glutamine, GABA, and aspartate.
| Amounts (nmol/g tissue) or % excess enrichment (%) |
Sham, n=8 |
HI, n=9 |
Si versus HIi | Sc versus HIc | Si versus Sc | HIi versus HIc | ||
| |
Ipsilateral |
Contralateral |
Ipsilateral |
Contralateral |
|
|
|
|
| Glycolysis and PDH | ||||||||
| [4,5-13C] Glutamate | 189.8±18.6 | 193.5±22.6 | 109.3±10.3 | 136.3±17.2 | ** | 0.06 | * | |
| [1,2-13C] GABA | 15.5±1.7 | 15.0±1.5 | 7.6±1.1 | 8.8±1.5 | *** | ** | ||
| [4,5-13C] Glutamine | 32.5±4.3 | 32.8±4.4 | 17.8±2.0 | 20.3±2.7 | * | * | ||
| [1,2-13C] Aspartate | 24.6±3.2 | 24.1±3.4 | 11.7±1.3 | 14.0±2.1 | ** | * | 0.09 | |
| [3,4-13C] Aspartate | 28.5±3.4 | 30.2±3.8 | 15.3±1.9 | 18.5±2.6 | ** | * | 0.08 | * |
| [1,2-13C] Glutamate | 28.4±2.3 | 28.4±3.1 | 15.5±2.0 | 19.9±2.9 | *** | 0.06 | 0.08 | |
| [1,2-13C] Glutamine | 6.8±0.9 | 6.6±0.5 | 4.5±0.3 | 5.1±0.6 | * | 0.06 | ||
| % [4,5-13C] Glutamate | 4.52±0.60 | 4.68±0.60 | 2.66±0.25 | 2.94±0.36 | * | * | 0.06 | |
| % [1,2-13C] GABA | 1.40±0.20 | 1.34±0.14 | 0.47±0.08 | 0.73±0.13 | ** | ** | * | |
| % [4,5-13C] Glutamine | 1.23±0.17 | 1.29±0.18 | 0.74±0.08 | 0.77±0.10 | * | * | ||
| % [1,2-13C] Aspartate | 2.14±0.25 | 2.14±0.25 | 1.22±0.11 | 1.33±0.17 | ** | * | ||
| % [3,4-13C] Aspartate | 2.48±0.27 | 2.69±0.26 | 1.59±0.15 | 1.78±0.19 | * | * | ** | * |
| % [1,2-13C] Glutamate | 0.67±0.07 | 0.69±0.08 | 0.37±0.04 | 0.43±0.06 | ** | * | ||
| % [1,2-13C] Glutamine | 0.26±0.03 | 0.26±0.02 | 0.19±0.02 | 0.19±0.02 | 0.08 | * | ||
| PPP and PDH | ||||||||
| [4-13C] Glutamate | 8.0±2.3 | 8.8±2.4 | 0.5±0.3 | 1.7±0.9 | * | * | ||
| [2-13C] GABA | NA | NA | NA | NA | ||||
| [4-13C] Glutamine | NA | NA | NA | NA | ||||
| % [4-13C] Glutamate | 0.20±0.06 | 0.22±0.06 | 0.01±0.01 | 0.04±0.02 | * | * | ||
| % [2-13C] GABA | NA | NA | NA | NA | ||||
| % [4-13C] Glutamine | NA | NA | NA | NA | ||||
| Glycolysis and PC | ||||||||
| [2,3-13C] Glutamate | 15.7±0.8 | 15.8±1.2 | 12.6±0.8 | 13.8±1.3 | * | |||
| [3,4-13C] GABA | ND | ND | ND | ND | ||||
| [2,3-13C] Glutamine | 24.9±2.1 | 23.9±2.7 | 17.2±1.8 | 20.8±2.7 | * | 0.07 | ||
| [2,3-13C] Aspartate | 10.1±0.9 | 9.9±0.8 | 5.8±0.6 | 6.0±0.9 | *** | ** | ||
| % [2,3-13C] Glutamate | 0.37±0.03 | 0.38±0.03 | 0.31±0.02 | 0.30±0.03 | 0.13 | 0.06 | ||
| % [3,4-13C] GABA | ND | ND | ND | ND | ||||
| % [2,3-13C] Glutamine | 0.94±0.08 | 0.94±0.11 | 0.71±0.08 | 0.79±0.11 | 0.07 | |||
| % [2,3-13C] Aspartate | 0.89±0.07 | 0.90±0.05 | 0.62±0.06 | 0.58±0.07 | ** | ** | ||
HI, hypoxic-ischemia; ND, not detectable; NA, not labeled above natural abundance; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase; PPP, pentose phosphate pathway; NMRS, nuclear magnetic resonance spectroscopy; P7, postnatal day 7.
P7 rats were injected with [1,2-13C]glucose and brain extracts were analyzed using 13C-NMRS. For more details, see Materials and Methods. Results are presented as mean±s.e.m. Isotopomeres labeled via the same metabolic pathways are listed together: top=labeled via glycolysis followed by PDH; middle=labeled via PPP followed by PDH; bottom=labeled via glycolysis followed by PC. P values are given in the four columns to the right: Si versus HIi=ipsilateral sham versus ipsilateral HI; Sc versus HIc=contralateral sham versus contralateral HI; Si versus Sc=ipsi- versus contralateral hemisphere in sham; HIi versus HIc=ipsi- versus contralateral hemisphere in HI. Near significant P values (<0.1) are given in numbers. *P<0.05, **P<0.01, ***P<0.001.